|
1) Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Periipheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006; 114: 1914-22
|
|
|
|
2) Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7
|
|
|
|
|
|
3) Tateisho-Yuyama E, Natsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a rando-mised controlled trial. Lancet. 2002; 360: 427-35
|
|
|
|
|
|
4) Hoshino J, Ubara Y, Hara S, et al. Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis. Circ J. 2007; 71: 1193-8
|
|
|
|
|
5) Eizawa T, Murakami Y, Matsui K, et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin. 2003; 19: 627-33
|
|
|
|
|
|
6) Herbrig K, Pistrosch F, Foerster S, et al. Endothelial progenitor cells in chronic renal insufficiency. Kidney Blood Press Res. 2006; 29: 24-31
|
|
|
|
|
|
7) Choi JH, Kim KL, Huh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 2004; 24: 1246-52
|
|
|
|
|
|
8) Westerweel PE, Hoefer IE, Blankestijn PJ, et al. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol. 2007; 292: F1132-40
|
|
|
|
|
|
9) Rodriquez-Ayala E, Yao Q, Holmen C, et al. Imbalance between detached circulating endothelial cells and endothelial progenitor cells in chronic kidney disease. Blood Purif. 2006; 24: 196-202
|
|
|
|
|
|
10) Sandri M, Adamas V, Gielen S, et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation. 2005; 111: 3391-9
|
|
|
|
|
|
11) Manfrendini F, Rigolin GM, Malagoni AM, et al. Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients. Int J Sports Med. 2007; 28: 368-73
|
|
|
|
|
|
12) Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization. A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002; 105: 3017- 24
|
|
|
|
|
|
13) Bahlmann FH, de Groot K, Mueller O, et al. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension. 2005; 45: 526-9
|
|
|
|
|
|
14) Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003; 102: 1340-6
|
|
|
|
|
|
15) Bahlmann FH, De Groot K, Spandau JM, et al. Erythropoietin regulates endothelial progenitor cells. Blood. 2004; 103: 921-6
|
|
|
|
|
|
16) Sturiale A, Coppolino G, Loddo S, et al. Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif. 2007; 25: 242-51
|
|
|
|
|
|
17) Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol. 2005; 289: F679-84
|
|
|
|
|